InMed Pharmaceuticals (INM) Amortizatization of Intangibles (2022 - 2026)
InMed Pharmaceuticals has reported Amortizatization of Intangibles over the past 4 years, most recently at $104818.0 for Q4 2025.
- For Q4 2025, Amortizatization of Intangibles rose 38.14% year-over-year to $104818.0; the TTM value through Dec 2025 reached $363904.0, up 1.37%, while the annual FY2025 figure was $321885.0, 16.38% down from the prior year.
- Amortizatization of Intangibles for Q4 2025 was $104818.0 at InMed Pharmaceuticals, up from $103478.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $104818.0 in Q4 2025 and troughed at $75876.0 in Q4 2024.
- A 4-year average of $92128.6 and a median of $93808.5 in 2023 define the central range for Amortizatization of Intangibles.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 38.14% in 2025 and fell as far as 19.33% in 2025.
- Year by year, Amortizatization of Intangibles stood at $90389.0 in 2022, then grew by 2.98% to $93085.0 in 2023, then dropped by 18.49% to $75876.0 in 2024, then soared by 38.14% to $104818.0 in 2025.
- Business Quant data shows Amortizatization of Intangibles for INM at $104818.0 in Q4 2025, $103478.0 in Q3 2025, and $78330.0 in Q2 2025.